Bevacizumab beyond disease progression for advanced non-small cell lung cancer: Does persistence have its rewards?

Cancer. 2016 Apr 1;122(7):1047-9. doi: 10.1002/cncr.29894. Epub 2016 Feb 1.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Bevacizumab / administration & dosage*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male

Substances

  • Antineoplastic Agents
  • Bevacizumab